Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by jopatcloon Nov 08, 2024 9:06am
118 Views
Post# 36302850

Alvira Macanovic reposted this !

Alvira Macanovic reposted this !Interesting see 
Alviras profile photo
Alvira Macanovic reposted this
The MedTech Talent Accelerator is thrilled to invite you to its second Explore MedTech Seminar for the 2024-2025 year! Please join us on October 24, 2024 (2pm EST) as the founder of her own consulting business, Alvira Macanovic shares key insights on developing AI medical devices tailored for startups.

Through covering market needs, technology integration, regulatory pathways, and user-centric design, Alvira Macanovic will guide you through the lifecycle from concept validation to market entry.

This seminar is open to ALL students and faculty
Date: October 24, 2024
Speaker: Alvira Macanovic
Location: Virtual via Zoom
Time: 12 am MST / 2 pm EST / 3 pm AST
RSVP Form: https://lnkd.in/g-76mjTi

See you all there!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities